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Chronic in vitro shear stress stimulates
endothelial cell retention on prosthetic
vascular grafts and reduces subsequent in
vivo neointimal thickness
Alan Dardik, MD, PhD, Ailian Liu, MD, and Barbara J. Ballermann, MD,
Baltimore, Md
Objective: The absence of endothelial cells at the luminal surface of a prosthetic vascular graft
potentiates thrombosis and neointimal hyperplasia, which are common causes of graft fail-
ure in humans. This study tested the hypothesis that pretreatment with chronic in vitro shear
stress enhances subsequent endothelial cell retention on vascular grafts implanted in vivo.
Methods: Cultured endothelial cells derived from Fischer 344 rat aorta were seeded onto the
luminal surface of 1.5-mm internal diameter polyurethane vascular grafts. The seeded grafts
were treated for 3 days with 1 dyne/cm2 shear stress and then for an additional 3 days with
1 or 25 dyne/cm2 shear stress in vitro. The grafts then were implanted as aortic interposi-
tion grafts into syngeneic rats in vivo. Grafts that were similarly seeded with endothelial cells
but not treated with shear stress and grafts that were not seeded with endothelial cells
served as controls. The surgical hemostasis time was monitored. Endothelial cell identity,
density, and graft patency rate were evaluated 24 hours after implantation. Endothelial cell
identity in vivo was confirmed with cells transduced in vitro with b -galactosidase comple-
mentary DNA in a replication-deficient adenoviral vector. Histologic, scanning electron
microscopic, and immunohistochemical analyses were performed 1 week and 3 months after
implantation to establish cell identity and to measure neointimal thickness.
Results: The pretreatment with 25 dyne/cm2—but not with 0 or 1 dyne/cm2—shear
stress resulted in the retention of fully confluent endothelial cell monolayers on the
grafts 24 hours after implantation in vivo. Retention of seeded endothelial cells was con-
firmed by the observation that b -galactosidase transduced cells were retained as a mono-
layer 24 hours after implantation in vivo. In the grafts with adherent endothelial cells
that were pretreated with shear stress, immediate graft thrombosis was inhibited and
surgical hemostasis time was significantly prolonged. Confluent intimal endothelial cell
monolayers also were present 1 week and 3 months after implantation. However, 1 week
after implantation, macrophage infiltration was observed beneath the luminal cell
monolayer. Three months after the implantation in vivo, subendothelial neointimal cells
that contained a –smooth muscle actin were present. The thickness of this neointima
averaged 41 ± 12 m m and 60 ± 23 m m in endothelial cell–seeded grafts that were pre-
treated with 25 dyne/cm2 shear stress and 1 dyne/cm2 shear stress, respectively, and
158 ± 46 m m in grafts that were not seeded with endothelial cells.
Conclusion: The effect of chronic shear stress on the enhancement of endothelial cell
retention in vitro can be exploited to fully endothelialize synthetic vascular grafts, which
reduces immediate in vivo graft thrombosis and subsequent neointimal thickness. (J Vasc
Surg 1999;29:157-67.)
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Endothelial cells serve anticoagulant and
antiproliferative functions in blood vessels. Under
physiologic conditions, endothelial cells adhere to
the luminal vessel wall with sufficient strength to
withstand the force of shear stress that is generated
by flowing blood. The adhesive strength is generat-
ed by cell-matrix interactions, which are mediated,
at least in part, by integrins that connect extracellu-
lar matrix–binding sites with intracellular focal adhe-
sion plaques.1 By contrast, endothelial cells that are
seeded onto the luminal surface of prosthetic vascu-
lar grafts are not usually retained after implantation
in vivo as a result of a lack of adhesive strength. Still,
endothelialization of prosthetic vascular grafts is a
goal for vascular reconstruction because seeded
endothelial cells could potentially reduce graft fail-
ure caused by thrombosis and could inhibit cell pro-
liferation associated with neointima-induced steno-
sis.2,3 The molecular mechanisms that lead to vascu-
lar thrombosis and neointima formation are
incompletely defined,4,5 and neither local nor sys-
temic pharmacologic treatments have improved clin-
ical outcome sufficiently to overcome these prob-
lems.6,7 Seeding of the luminal synthetic graft sur-
face with endothelial cells8 improves patency rates
and reduces early thrombus formation in some ani-
mal models.9-11 Nevertheless, there is a rapid loss of
cells after exposure to shear stress in vitro12 or
implantation in vivo. For instance, Rosenman et al13
reported that up to 40% of seeded cells are lost at 1
hour and that more than 80% are lost by 24 hours
after implantation in vivo. Autologous human
endothelial cells that are seeded onto vascular grafts
fail to improve graft patency rates, presumably as a
result of the loss of the seeded cells from the
grafts.9,14
Prolonged exposure of endothelial cells to shear
stress leads to cell flattening, which limits cell surface
shear stress gradients,15 reduces expression of the
pro-proliferative mediators endothelin-116 and
platelet derived growth factor–B,17 and induces a
nearly 40-fold higher density of Weibel-Palade bod-
ies.18 These findings are suggestive of endothelial
cell differentiation. Chronic shear stress also pro-
motes the adhesion of aortic endothelial cells to
prosthetic vascular grafts in vitro.19 Bovine aortic
endothelial cells that were cultured for 6 days on the
luminal surface of polyurethane grafts without shear
stress were dislodged from the grafts by acute shear
stress, whereas the cells that were similarly cultured
on grafts but preconditioned with shear stress at 1
dyne/cm2 for 3 days and then at 25 dyne/cm2 for
an additional 3 days were not dislodged. The rate of
fibrin clot formation also was significantly less in the
grafts that were pretreated with shear stress and that
retained endothelium than in the grafts that were
not pretreated from which the cells had been dis-
lodged.19
The current study addressed the question of
whether poor endothelial cell adhesion on prosthet-
ic vascular grafts in vivo, which is currently a major
obstacle to graft endothelialization, could be over-
come by pretreating endothelial cells with shear
stress for several days in vitro.
METHODS
Cell culture. Clonal rat aortic endothelial cell
lines were derived from Fischer 344 rat aorta. A seg-
ment of the abdominal aorta was excised from a rat
under anesthesia, inverted, and treated with 1 mg/mL
collagenase (type IV; Sigma, St Louis, Mo) in RPMI
1640 medium at 37°C for 20 minutes. The dislodged
cells were sedimented with centrifugation, washed
three times with RPMI 1640, and then resuspended in
endothelial cell basal medium (EBM; Clonetics, San
Diego, Calif), supplemented with penicillin (5000
IU/mL), streptomycin (5000 m g/mL), heparin (1
m g/mL), fetal calf serum (15%), and bovine brain
extract (3.1 mg/500 mL; Clonetics). The cells were
plated on 3 to 5 gelatin-coated culture plates at 
a density of approximately 1000 cells per 70-cm2
plate. On average, 5 to 10 endothelial cell colonies
emerged on each plate. These were subcloned with
cloning cylinders and expanded with supplemented
EBM medium and gelatin-coated plates. All the
endothelial cell lines were homogeneous clonal iso-
lates that exhibited acetylated low density–lipopro-
tein uptake and contained von Willebrand’s factor
(vWF) with indirect immunofluorescence, as previ-
ously described.20 Endothelial cells between passages
8 and 25 were used.
Shear stress. Shear stress was calculated from
Poiseuille’s equation: t = 4h Q/p r3, where t = shear
stress, h = fluid viscosity, Q = medium fluid flow
rate, and r = radius of the cylinder. The viscosity of
the cell culture medium was measured with a
Cannon-Manning tube viscometer (International
Research Glassware, Kenilworth, NJ) and ranged
from 0.0088 to 0.0092 poise.19 The viscosity of
whole blood is approximately 0.035 poise.21
Cell culture on vascular grafts with shear
stress. Segments of untreated spun polyurethane
grafts, (with a hardness of 50 on the Shore Hardness
Scale D; Corvita Corporation, Miami, Fla), that had
a 1.5-mm inner diameter and were 5 cm in length
were coated with 4% bovine gelatin, air-dried, placed
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into shear stress chambers,18 and sterilized with eth-
ylene oxide. The gelatin was cross-linked with 2.5%
glutaraldehyde for 30 minutes at room temperature,
followed by neutralization with 1% glycine. The
grafts were washed three times with 10 mL of culture
medium and then were seeded with 2 to 3 · 105
cells/cm2. The cells were allowed to attach for 4
hours as previously described.18 Shear stress then was
initiated at 1 dyne/cm2 for the first 3 days to allow
cell attachment before exposure to higher levels of
shear stress.12 Shear stress then was increased to 25
dyne/cm2 (arterial shear stress) or maintained at 1
dyne/cm2 (venous shear stress) for an additional 3
days. In 10 grafts, the endothelial cells were seeded
and allowed to attach but were implanted immedi-
ately without any in vitro culture or shear stress pre-
treatment because in vitro culture for 6 days without
flowing medium leads to uniform death of rat aortic
endothelial cells (data not shown). Control grafts
that were not seeded with cells were processed iden-
tically and exposed to 25 dyne/cm2 shear stress
before implantation. Because such grafts uniformly
underwent thrombosis during the first 24 hours after
implantation, grafts that were neither coated with
gelatin nor seeded with cells were used as additional
controls for 1-week and 3-month time points.
Implantation of vascular grafts in vivo.
Female Fischer 344 rats (Charles River Laboratories,
Wilmington, Mass) that weighed from 150 to 175
gm underwent anesthesia with inhalation of
methoxyflurane. After a lower midline incision was
made, dissection was carried down to the aorta, a
1.5-cm section of the infrarenal aorta was clamped
with an Acland clamp approximator (Microsurgery
Instruments, Inc, Bellaire, Tex), and a piece of the
aorta, approximately 0.7 cm in length, was excised.
The ends of the aorta and the graft to be inserted
were flushed with 0.5 mL of heparinized saline solu-
tion (25 U/100 mL). No systemic heparinization
was performed. The grafts were divided into 1.0-cm
sections for implantation in vivo, and a portion of
each graft was taken for preimplantation analysis. All
the grafts were kept in medium on ice and then
washed in normal saline solution immediately before
use. The grafts were sewn into the infrarenal aorta
with interrupted 10-0 nylon sutures (MIC, Bellaire,
Tex), with a standard microsurgical technique. The
aortic cross-clamp time ranged from 24 to 57 min-
utes (35 ± 7 minutes, mean ± standard deviation)
and did not differ between the groups. After the
removal of the Acland clamp and the control of the
suture line bleeding with light pressure, graft paten-
cy was confirmed with the presence of lateral pulsa-
tions. The surgical hemostasis time was defined as
the time interval from the removal of the Acland
clamp until the cessation of blood transudation
through the graft interstices. Blood transudation was
checked every 30 seconds. The abdomen was irri-
gated and closed with an absorbable suture, and 10
mL of sterile saline solution were injected intraperi-
toneally to circumvent volume depletion. The skin
then was closed, and the animal was allowed to
recover from the anesthesia. Food and water were
made available immediately afterwards. All the ani-
mal care complied with the “Principles of
Laboratory Animal Care” (formulated by the
National Society for Medical Research) and the
Guide for the Care and Use of Laboratory Animals
(NIH Publication No. 86-23, revised 1985) and
received approval from the Johns Hopkins Animal
and Care Use Committee, Animal Welfare
Assurance No. A-3272-01. A single surgeon per-
formed all the operations.
Graft removal and histology. The grafts were
removed at 24 hours, 7 days, or 3 months after place-
ment in vivo. The rats again underwent anesthesia,
the abdomen was opened, and the grafts were
inspected for patency. Patency was determined with
the following methods: 1) a visual inspection for lat-
eral pulsations; 2) the presence of visible intraluminal
thrombus; 3) the presence of prograde flow in the
distal vessel, also termed the strip test22; and 4) the
presence of pulsatile blood flow after distal arterioto-
my. After removal, the graft was flushed with 1 mL of
saline solution, immersion fixed in 10% formalin, and
paraffin embedded, and three to six 10- m m serial sec-
tions from the midpoint of each graft were stained
with hematoxylin and eosin.23 For those grafts that
were examined by means of scanning electron
microscopy, a 2-mm section of the mid-portion of
the graft was placed into a formalin-paraformalde-
hyde buffer and processed as previously described.18
For all the grafts that were kept in vivo for 24 hours,
the number of cell nuclei per mm at the luminal sur-
face was counted in three to six sections of the same
graft. Intraexperimental variability for different sec-
tions of the same graft was routinely less than 10%.
Cell retention then was defined as the percentage of
cells/mm that remained at the luminal surface, with
cells/mm on the same graft preimplantation serving
as the reference. For the grafts that were left in place
for 3 months, the thickness of the neointima was
measured with an eyepiece micrometer, at eight
equidistant points around the circumference of three
to six serial cross-sections that were taken from the
midpoint of each graft. 
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Immunocytochemistry. The sections also were
processed for immunohistochemical examination, as
previously described,24 with purified rabbit polyclon-
al anti-vWF immunoglobulin G (IgG; 1:1000; Dako,
Carpinteria, Calif), mouse anti- a –smooth muscle
actin monoclonal IgG (1:400; Dako), and mouse
monoclonal anti-rat macrophage IgG (Clone EDI,
1:300; Accurate, Westbury, NY). Endogenous perox-
idase was quenched with 3% hydrogen peroxide for
20 minutes. The sections were treated with 0.4%
pepsin (Sigma) in a 0.01-N HCL solution for 30
minutes at 37°C. For the detection of a –smooth
muscle actin, the sections were microwave treated.
Secondary antibodies were biotinylated goat
anti–rabbit IgG (1:200; Vector Laboratories,
Burlingame, Calif) for vWF staining and biotinylated
goat anti–mouse IgG (1:300; Jackson Immuno-
Research, West Grove, Pa) for a -actin and macro-
phage staining. Detection was performed with 3,3´-
diaminobenzidine with the ABC kit (Vector).
Counterstaining was performed with Mayer’s modi-
fied hematoxylin. Normal rat aorta served as positive
control tissue for vWF and a –smooth muscle actin
antibody, and normal rat spleen served as positive
control for EDI antibody staining. As negative con-
trols, the primary antibody was omitted or substitut-
ed with rabbit or mouse IgG (Sigma) from animals
that had not undergone immunization. No staining
occurred in the negative control sections. Indirect
immunofluorescence was not performed as a result of
the autofluorescence of polyurethane grafts (data not
shown).
Cell transfection with b -galactosidase ade-
novirus. The Escherichia coli b -galactosidase (Lac-Z)
gene was inserted into the transient expression vector
p D E1sp1B (Microbix Systems, Ontario, Canada)
under the control of the cytomegalovirus pro-
moter and upstream from a polyadenylation signal
(p D E1sp1BlacZ). The recombinant replication-
deficient Lac-Z adenovirus (adeno–lac Z) was pro-
duced with in vitro homologous recombination in
human embryonic kidney 293 (HEK 293) cells
between p D E1sp1BlacZ and plasmid pJM17.
Individual plaques of adeno–lac Z were identified by
X-gal staining in infected HEK 293 cells. These
plaques were amplified and purified with ultracentrifu-
gation through a CsCl gradient followed by dialysis
against 10% glycerol in saline solution. The stock viral
titer, determined in HEK 293 cells, was 2 · 1011
plaque-forming units/mL. After 5 days of shear stress
treatment in vitro, the grafts were disconnected from
the pump circuit and incubated with 2 mL adeno–lac
Z virus, which was diluted to 5 · 107 plaque-forming
units/mL in EBM that contained 1.5% serum, for 2
hours at 37°C. The grafts then were washed with cul-
ture medium and reconnected to the pump circuit for
the final 24 hours of shear stress treatment. The grafts
then were implanted in vivo, as described above, and
examined for X-gal staining at 24 hours and 7 days
after implantation. A portion of the same graft was not
implanted to evaluate b -galactosidase expression
before implantation. After graft removal and flushing
with saline solution, the graft was fixed with 0.5%
gluteraldehyde and washed with saline solution.
Staining was performed with X-gal for 18 hours at
37°C. The graft then was embedded in paraffin and
serially sectioned; some sections were counterstained
with eosin to stain cells that did not contain the b -
galactosidase reaction product. False-positive staining
was ruled out by performing b -galactosidase staining
on grafts, which were seeded with cells that were not
transduced with b -galactosidase complementary
DNA, before and after implantation in vivo (data not
shown). 
RESULTS
In vivo retention of endothelial cells after
shear stress treatment. Confluent monolayers of
endothelial cells were observed lining the lumen of
the grafts after pretreatment with 1 (n = 27) and 25
dyne/cm2 (n = 60) shear stress before implantation
in vivo (Fig 1A). Some cells also were present in the
graft interstices before implantation (data not
shown). Endothelial cells were similarly observed on
the luminal surfaces of the grafts 24 hours after
implantation in vivo (Fig 1B,C). These cells were
immunoreactive with anti-vWF antibody (data not
shown). Similarly, the cells that were observed in the
interstices of the grafts 24 hours after implantation
in vivo displayed vWF immunoreactivity (data not
shown).
Quantitative analysis of luminal cell retention
after 24 hours in vivo is shown in Fig 2A. Before
implantation, the mean cell number per millimeter
of luminal graft surface was 24.2 ± 7.9 in grafts that
were pretreated with 25 dyne/cm2 shear stress and
remained 23.7 ± 8.5 after 24 hours in vivo (mean ±
standard deviation; n = 7). The mean cell density at
the luminal surface of the grafts that were pretreat-
ed with 1 dyne/cm2 shear stress was 22.8 ± 4.9
cells/mm before implantation and 11.7 ± 2.9
cells/mm 24 hours after implantation in vivo (n =
6). On the grafts that were not exposed to shear
stress, the cell density was 8.1 ± 2.4 cells/mm before
implantation and 3.7 ± 2.4 cells/mm 24 hours after
implantation in vivo (n = 4). Thus, endothelial cell
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retention 24 hours after implantation in vivo was
much greater on the grafts that were pretreated with
25 dyne/cm2 as compared with the grafts that were
pretreated with 1 dyne/cm2 shear stress (P < .0001,
Student t test). 
Effect of endothelial cells on thrombosis and
hemostasis time. All the grafts that were pretreat-
ed with 25 dyne/cm2 shear stress were patent 24
hours after implantation in vivo. Six of seven
polyurethane grafts that were pretreated with 1
dyne/cm2 shear stress and 4 of 5 grafts that con-
tained endothelial cells but were not pretreated with
shear stress remained patent 24 hours after implan-
tation. Because all the endothelial cell–seeded grafts
were precoated with gelatin, grafts that were similar-
ly coated with gelatin but not seeded with endothe-
lial cells were also implanted. These uniformly
underwent thrombosis at 24 hours (n = 4; Fig 1D).
Polyurethane grafts that were neither coated with
gelatin nor seeded with endothelial cells remained
patent (n = 7; data not shown). 
The time to achieve surgical hemostasis was sig-
nificantly longer for the endothelial cell–lined, shear
stress–pretreated grafts as compared with the grafts
without endothelial cells or the grafts that were
seeded with cells but not exposed to shear stress (Fig
2B; P < .005, analysis of variance). The hemostasis
times tended to be longer in the grafts that were pre-
treated with 25 dyne/cm2, as compared with 1
dyne/cm2 shear stress, although this difference did
not achieve significance.
Evaluation of cell identity. To determine
whether the cells that were observed at the luminal
surface of the implanted grafts were those that were
originally seeded onto the graft, the endothelial cells
that were seeded onto the polyurethane grafts and
pretreated with 25 dyne/cm2 shear stress were
infected with a replication-deficient adenovirus that
carried the bacterial b -galactosidase gene. Before
implantation, a confluent monolayer of endothelial
cells was present on the luminal graft surface and
cells were present within the interstices of the graft,
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Fig 1. Light-microscopic appearance of endothelial cell–lined vascular grafts. Endothelial
cell–seeded polyurethane graft treated with 25 dyne/cm2 mean shear stress (A) before implan-
tation and (B) 24 hours after implantation in vivo. C, Endothelial cell–seeded polyurethane
graft treated with 1 dyne/cm2 mean shear stress shown 24 hours after implantation in vivo. D,
Gelatin-coated polyurethane graft without endothelial cells 24 hours after implantation in vivo.
E and F, Polyurethane graft with shear stress (25 dyne/cm2) treated endothelial cells that were
also transduced with Lac-Z adenovirus, shown 24 hours after implantation in vivo.
Magnification: A to C and F, 100· ; D, 40· ; and E, 20· . 
which was similar to the grafts that were not infect-
ed with adenovirus (n = 4; data not shown). All the
observed cells exhibited b -galactosidase activity, and
all the b -galactosidase staining was cell-specific.
Twenty-four hours after implantation in vivo (Fig
1E,F), the mean luminal cell density was 104% of
that before implantation on two separate grafts that
were seeded with adeno LacZ–transduced endothe-
lial cells—approximately 95% of the luminal cells
observed on the grafts 24 hours after implantation
stained blue (n = 2). At 1 week after implantation,
the level of LacZ expression was significantly
reduced as compared with the findings at 1 day after
implantation (n = 2; data not shown), both because
a lower percentage of cells in the graft expressed
Lac-Z and because the level of expression in positive
cells was reduced. Because the grafts contain many
nonendothelial cells at 1 week, the fraction of Lac-Z
expressing cells was not determined.
Scanning electron micrographs of grafts before
implantation and 24 hours after implantation are
shown in Fig 3. A confluent monolayer of endothe-
lial cells was observed on all grafts that were pre-
treated with 25 dyne/cm2 (n = 2; Fig 3A) or 1
dyne/cm2 (n = 2; not shown) before implantation.
The grafts that were pretreated with 25 dyne/cm2
shear stress also contained confluent, undisrupted
monolayers 24 hours after implantation (n = 2; Fig
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Fig 2. A, Endothelial cell density on polyurethane vascu-
lar grafts treated with 0, 1, or 25 dyne/cm2 shear stress,
before (hatched bars) and 24 hours after implantation in
vivo (solid bars). B, Surgical hemostasis time after re-estab-
lishment of aortic circulation for unseeded grafts, seeded
grafts not treated with shear stress, and seeded grafts treat-
ed with 1 or 25 dyne/cm2 shear stress.
*P < .0001, Student t test.
Fig 3. Scanning electron microscopy of endothelial
cell–seeded polyurethane grafts. Endothelial cell–seeded
graft treated with 25 dyne/cm2 mean shear stress (A) before
implantation and (B) 24 hours after implantation in vivo. C,
Endothelial cell–seeded polyurethane graft treated with 1
dyne/cm2 mean shear stress shown 24 hours after implanta-
tion in vivo. Magnification, 420· .
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 1 Dardik, Liu, and Ballermann 163
Fig 4. Nature of intimal cell layer on polyurethane grafts 1 week and 3 months after implanta-
tion in vivo. Grafts were harvested 1 week (A to C) or 3 months (D to I) after implantation in
vivo. A and D, Anti–von Willebrand’s factor antibody to identify endothelial cells. B and E,
Anti-a smooth muscle actin antibody to identify neointimal myofibroblasts or smooth muscle
cells. C and F, EDI antibody to identify macrophages. Magnification: A to F, 160· . G to I,
Polyurethane grafts 3 months after implantation in vivo. G, polyurethane graft neither coated
with gelatin or seeded with endothelial cells. H, Endothelial cell–seeded polyurethane graft pre-
treated with 1 dyne/cm2 mean shear stress. I, Endothelial cell–seeded polyurethane graft pre-
treated with 25 dyne/ cm2 mean shear stress. Magnification: G to I, 64· . 
3B). The cells on these grafts appeared flatter than
the cells on the same grafts before implantation. The
endothelial cells on the grafts that were pretreated
with 1 dyne/cm2 were more rounded, and not all
areas of the grafts were covered by cells (n = 2; Fig
3C). After implantation in vivo, platelet adhesion
was observed on grafts that were pretreated with 1
dyne/cm2 (Fig 3C) but not on grafts that were pre-
treated with 25 dyne/cm2 (Fig 3B).
Characterization of the graft neointima 1
week and 3 months after implantation. One
week after implantation in vivo, all the grafts that
were seeded with endothelial cells and pretreated
with shear stress contained a confluent monolayer of
cells immunoreactive with anti-vWF antibody at
their luminal surfaces (n = 2; Fig 4A). In grafts that
were not seeded with endothelial cells, no cells were
observed at the luminal surface 1 week after implan-
tation (n = 2, data not shown). Also, at 1 week after
implantation, cells were observed in most areas
beneath the luminal monolayer. These were
immunoreactive with antimacrophage (Fig 4C) but
not with a –smooth muscle actin antibody (Fig 4B)
and were observed in endothelial cell–seeded, shear
stress pretreated grafts (n = 2). No macrophages
were observed at 1 week after implantation in grafts
that were not seeded with endothelial cells (n = 2;
data not shown).
At 3 months after implantation, a neointimal
layer was present in all the grafts (Fig 4), but this was
much thinner in the grafts that were pretreated with
1 or 25 dyne/cm2 and that contained adherent
endothelial cells before implantation as compared
with the grafts that had been implanted without
endothelial cells (Fig 4G) or the grafts that had been
seeded with endothelial cells and not treated with
shear stress (data not shown). All the grafts that were
previously seeded with endothelial cells contained a
luminal cell monolayer that stained strongly with
vWF antibody (n = 2; Fig 4D). The control grafts
that were not seeded with endothelial cells also con-
tained luminal endothelium 3 months after implan-
tation (n = 4; data not shown). Subendothelial cell
macrophages were not observed 3 months after graft
implantation (Fig 4F). Instead, the subendothelial
cell layer of all the grafts, whether seeded with
endothelial cells or not, exhibited a –smooth muscle
actin immunoreactivity (Fig 4E).
Quantification of neointimal thickness after 3
months in vivo (Fig 5) showed a neointimal layer
158 ± 46 m m in grafts without endothelial cells at
the time of implantation (n = 4). By contrast, the
neointima measured 60 ± 23 and 41 ± 12 m m in
grafts that were seeded with endothelial cells and
pretreated with 1 dyne/cm2 (n = 5) or 25 dyne/cm2
(n = 4) shear stress, respectively. The mean lumen
diameter was reduced, on average, by 21% ± 6%, 8%
± 3%, and 5% ± 2% in unseeded, 1 dyne/cm2 pre-
treated grafts, and 25 dyne/cm2 pretreated grafts,
respectively. Thus, the presence of shear stress pre-
treated endothelial cells at the time of graft implan-
tation significantly reduced neointimal thickness and
graft lumen narrowing 3 months later (P = .005,
analysis of variance).
DISCUSSION
This study explored the effect of chronic in vitro
shear stress pretreatment on endothelial cell reten-
tion in vivo. The implantation of shear stress pre-
treated endothelial cells on vascular grafts in vivo
resulted in retention of a confluent endothelial cell
monolayer, reduced immediate thrombogenicity,
and reduced neointima thickness 3 months later.
The poor clinical performance of small diameter
(<4 mm inside diameter) vascular grafts is caused, at
least in part, by the absence of a functional endotheli-
um.25 Also, failure of larger prosthetic vascular grafts,
particularly those used for vascular bypass grafting or
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Fig 5. Quantification of neointimal thickness 3 months
after graft implantation. Mean thickness of neointimal
layer, measured at 8 equidistant points around circumfer-
ence of 3 to 6 cross-sections taken from midpoint of graft
was: A, 158 ± 46 m m (n = 4) for grafts without endothe-
lial cells; B, 60 ± 23 m m (n = 5) for endothelial cell–seed-
ed grafts pretreated with 1 dyne/cm2; and C, 41 ± 12 m m
(n = 4) for endothelial cell–seeded grafts pretreated with
25 dyne/cm2 shear stress.
hemodialysis, is largely a result of neointimal hyper-
plasia at the anastomoses and elsewhere in the graft.26
In humans, prosthetic vascular graft endothelializa-
tion is extremely slow and almost never complete.27 It
has been postulated that endothelialization of pros-
thetic graft material before implantation might reduce
the incidence rate of graft thrombosis and the long-
term rates of neointima formation.28-30
The extent of graft endothelialization is influenced
by many factors, including graft material,31 coating
matrix,32 and endothelial-cell growth factors.33,34
Given that the adhesive strength of endothelial cells
increased with chronic exposure to arterial levels of
shear stress,19 we postulated that shear stress pretreat-
ment also enhances endothelial cell retention on vas-
cular grafts implanted in vivo. To perform such in vivo
studies, syngeneic rat endothelial cells were used.
Rat aortic endothelial cells that were seeded on
the inner lumen of polyurethane grafts and exposed
to shear stress for 6 days in vitro formed confluent
endothelial monolayers (Fig 1 and 2). The cells in
these monolayers appeared morphologically normal
with scanning electron microscopy (Fig 3), even
though the polyurethane grafts have no arterial
media. The cells generally were oriented along the
direction of flow, although in some areas the align-
ment was along the graft fiber (Fig 3A). The finding
of nonuniform cell orientation on the fibers could
reflect nonlaminar flow in areas where fibers overlap,
focal cell migration into the graft interstices (Fig 1C,
E), or plasticity of the cells after exposure to shear
stress.35 The lack of an underlying media also could
alter cell alignment. In contrast to findings with
shear stress pretreated grafts, the cell density on
grafts that were seeded with endothelial cells and
implanted immediately without shear stress pretreat-
ment was much lower (Fig 2). Thus, full endothe-
lialization of prosthetic vascular grafts was promoted
when the cells were cultured in vitro for several days
before implantation. Grafts that were seeded with
endothelial cells and then implanted immediately
have been used in patients, but low-density seeding
did not alter long-term graft performance.36
Grafts that were exposed to shear stress at 25
dyne/cm2 during the 3 days before implantation
retained their luminal endothelial cells 24 hours and
1 week after implantation in vivo. This represents a
much greater degree of graft endothelialization than
previously reported.13,37 The number of cells that
remained on grafts, in vivo, was much less in those
that were pretreated with 1 dyne/cm2 shear stress,
as compared with 25 dyne/cm2 shear stress, during
the 3 days before implantation. Thus, even though a
similar degree of preimplantation endothelialization
was achieved (Fig 2A), the level of in vitro shear
stress pretreatment determines, at least in part, the
degree of endothelial cell retention on polyurethane
grafts. These results are consistent with previous
findings that endothelial cells not exposed to shear
stress were dislodged from polyurethane vascular
grafts when exposed to acute shear stress.19 That the
cells retained at the luminal surface are those that
were originally seeded can be concluded from the
finding that grafts without cells do not sponta-
neously undergo endothelialization in 24 hours or 7
days and from the experiments (Fig 1E,F) that
showed that endothelial cells transduced with aden-
ovirus-LacZ before implantation are present 24
hours after implantation in vivo. Thus, in vivo
endothelial cell retention on vascular grafts is
enhanced significantly with in vitro pretreatment
with arterial (25 dyne/cm2) shear stress, which
results in retention of a confluent intimal layer of
endothelial cells 24 hours after implantation in vivo.
All the endothelial cell–seeded grafts were initial-
ly pretreated with gelatin because cells did not attach
to uncoated grafts. Gelatin-coated grafts without
endothelial cells uniformly underwent thrombosis
within 24 hours (Fig 1D). Because gelatin activates
platelets, the thrombosis of the grafts without
endothelial cells was expected. The presence of the
endothelial cells markedly inhibited the early throm-
bosis of gelatin-coated grafts, which is in keeping
with the physiologic anticoagulant properties of
endothelial cells. The time to achieve surgical hemo-
stasis after the re-establishment of blood flow also
was monitored. For the grafts that were not treated
with shear stress, whether or not they were seeded
with endothelial cells, hemostasis time was much
shorter than that observed for endothelial cell–seed-
ed grafts that were pretreated with shear stress (Fig
2B). Thus, fluid shear stress not only facilitates the
lining of grafts with adherent endothelial cells, but
shear stress–treated cells also exhibit the normal
physiologic function of inhibiting local blood coag-
ulation in vivo, as previously observed in vitro.19
Subendothelial macrophage accumulation in grafts
at 1 week, but not at 3 months, after implantation (Fig
4C and 4F) suggests that the implanted endothelial
cells support monocyte/macrophage chemotaxis. It is
not yet clear whether the macrophages are recruited
from the luminal or the abluminal compartment.
Macrophage recruitment could be related to enhanced
intercellular adhesion molecule–1 or to monocyte
chemotactic protein-1 expression, which was previous-
ly shown to occur in response to acute shear stress.38,39
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At 3 months after implantation in vivo, all the
grafts, whether seeded with endothelial cells or not,
had developed neointima, although the neointima was
much thinner in the fully endothelialized grafts than in
those that were implanted without endothelial cells
(Fig 5). A previous study that showed that cell seeding
does not reduce intimal thickness was performed in
different animal species, with a different model of arte-
rial injury at different time points of neointima forma-
tion, with venous endothelial cells, and with cells not
conditioned by shear stress.40 Our finding of a thinner
neointima in endothelialized grafts supports the theo-
ry that endothelial cells not only serve anticoagulant
functions in blood vessels but also inhibit myofibrob-
last proliferation or migration. Neointima formation
that leads to stenosis and thrombosis is a significant
cause of long-term graft failure,2,3 including prosthet-
ic vascular grafts used for dialysis.41,42 This study sug-
gests that graft neointimal hyperplasia can be mini-
mized if a confluent, adherent monolayer of endothe-
lial cells is established on the luminal surface of vascular
grafts before implantation in vivo.
In summary, with the treatment of endothelial
cells that were seeded on polyurethane vascular
grafts with shear stress in vitro before implantation
in vivo, full endothelialization of grafts was achieved
and persisted after implantation in vivo. The pres-
ence of retained endothelial cell monolayers on
grafts resulted in reduced immediate thrombogenic-
ity and late neointimal thickness. Shear stress pre-
treatment, possibly in combination with other meth-
ods that improve endothelialization of prosthetic
vascular grafts, could potentially be used in clinical
medicine to reduce the incidence rate of graft
thrombosis. In addition, it is tempting to speculate
that pretreatment with shear stress might improve
retention of endothelial cells that stably express
genes of interest43,44 for in vivo gene delivery.
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